With the widespread implementation of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging, the detection of early oligorecurrent PCa lesions at biochemical recurrence has significantly improved [1]. Here, FOLH1 is linked to posterior cortical atrophy.